Market Tracker

11/25 6:05pm ET

Apricus Biosciences Inc (NASDAQ:APRI)

1.31
Data as of Nov 25
 -0.03 / -2.24%
Today’s Change
1.12
Today|||52-Week Range
2.71
-50.57%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close1.34
Today’s open1.33
Day’s range1.30 - 1.35
Volume80,468
Average volume (3 months)151,458
Market cap$58.5M
Dividend yield--
Data as of 3:59pm ET, 11/25/2014

Growth & Valuation

Earnings growth (last year)+60.59%
Earnings growth (this year)+49.28%
Earnings growth (next 5 years)--
Revenue growth (last year)-70.16%
P/E ratioNM
Price/Sales36.32
Price/Book4.58

Competitors

 Today’s
change
Today’s
% change
PARNParnell Pharmaceutic...-0.17-3.79%
ADXSAdvaxis Inc+0.01+0.34%
COCPCocrystal Pharma Inc+0.07+15.43%
MTEXMannatech Inc+0.52+2.23%
Data as of 4:00pm ET, 11/25/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$2.5M
Annual profit (last year)-$15.7M
Net profit margin-632.02%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Richard W. Pascoe
Chief Financial Officer, Secretary &
Senior VP
Steven Robert Martin
Corporate headquarters
San Diego, California

Forecasts